NCT05116176
TRAjectories and CLinical ExpeRiences of ICD Therapy Study
Enrolling by Invitation
Not specifiedAges 65+ObservationalBeth Israel Deaconess Medical CenterInvestigator-initiated
~500 participants
Updated 2026-05-07 on ClinicalTrials.gov
What's tested:Implantable cardioverter-defibrillators
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Clinical Trajectories after ICD implantation
Measured over Patients will be followed quarterly for 18 months or to death.
+2 more outcomes measured
Conditions
Where it's being run
1 sites across 1 statesMassachusetts1
Study leadership
- Daniel B Kramer, MD, MPH · PRINCIPAL_INVESTIGATOR · Beth Israel Deaconess Medical Center
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- Clinical Trajectories after ICD implantationPatients will be followed quarterly for 18 months or to death.
Group-based trajectory modeling will identify patient clusters with distinct trajectories of functional status and quality of life following ICD implantation.
- Outcomes after ICD ImplantationUp to 18 months
Death/Poor Quality of Life (combined endpoint)
- Semi-competing risks model of deaths and/or ICD shocksUp to 18 months
Personalized outcome profiles for death +/- ICD shocks